Show simple item record

dc.contributor.authorGale, K B
dc.contributor.authorFord, A M
dc.contributor.authorRepp, R
dc.contributor.authorBorkhardt, A
dc.contributor.authorKeller, C
dc.contributor.authorEden, Tim O B
dc.contributor.authorGreaves, M F
dc.date.accessioned2010-03-23T14:46:31Z
dc.date.available2010-03-23T14:46:31Z
dc.date.issued1997-12-09
dc.identifier.citationBacktracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. 1997, 94 (25):13950-4 Proc. Natl. Acad. Sci. U.S.A.en
dc.identifier.issn0027-8424
dc.identifier.pmid9391133
dc.identifier.urihttp://hdl.handle.net/10541/94685
dc.description.abstractEpidemiological evidence has suggested that some pediatric leukemias may be initiated in utero and, for some pairs of identical twins with concordant leukemia, this possibility has been strongly endorsed by molecular studies of clonality. Direct evidence for a prenatal origin can only be derived by prospective or retrospective detection of leukemia-specific molecular abnormalities in fetal or newborn samples. We report a PCR-based method that has been developed to scrutinize neonatal blood spots (Guthrie cards) for the presence of numerically infrequent leukemic cells at birth in individuals who subsequently developed leukemia. We demonstrate that unique or clonotypic MLL-AF4 genomic fusion sequences are present and detectable in neonatal blood spots from individuals who were diagnosed with acute lymphoblastic leukemia at ages 5 months to 2 years and, therefore, have arisen during fetal hematopoiesis in utero. This result provides unequivocal evidence for a prenatal initiation of acute leukemia in young patients. The method should be applicable to other fusion genes in children with common subtypes of leukemia and will be of value in attempts to unravel the natural history and etiology of this major subtype of pediatric cancer.
dc.language.isoenen
dc.subjectCancer DNAen
dc.subjectMyeloid-Lymphoid Leukaemia Proteinen
dc.subjectPrecursor Cell Lymphoblastic Leukaemia-Lymphomaen
dc.subject.meshArtificial Gene Fusion
dc.subject.meshBase Sequence
dc.subject.meshChild, Preschool
dc.subject.meshDNA Primers
dc.subject.meshDNA, Neoplasm
dc.subject.meshDNA-Binding Proteins
dc.subject.meshFetal Blood
dc.subject.meshHumans
dc.subject.meshInfant
dc.subject.meshInfant, Newborn
dc.subject.meshMolecular Sequence Data
dc.subject.meshMyeloid-Lymphoid Leukemia Protein
dc.subject.meshNuclear Proteins
dc.subject.meshPolymerase Chain Reaction
dc.subject.meshPrecursor Cell Lymphoblastic Leukemia-Lymphoma
dc.subject.meshProto-Oncogenes
dc.subject.meshRetrospective Studies
dc.subject.meshTranscription Factors
dc.titleBacktracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots.en
dc.typeArticleen
dc.contributor.departmentLeukaemia Research Fund Centre at the Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, United Kingdom.en
dc.identifier.journalProceedings of the National Academy of Sciences of the United States of Americaen
html.description.abstractEpidemiological evidence has suggested that some pediatric leukemias may be initiated in utero and, for some pairs of identical twins with concordant leukemia, this possibility has been strongly endorsed by molecular studies of clonality. Direct evidence for a prenatal origin can only be derived by prospective or retrospective detection of leukemia-specific molecular abnormalities in fetal or newborn samples. We report a PCR-based method that has been developed to scrutinize neonatal blood spots (Guthrie cards) for the presence of numerically infrequent leukemic cells at birth in individuals who subsequently developed leukemia. We demonstrate that unique or clonotypic MLL-AF4 genomic fusion sequences are present and detectable in neonatal blood spots from individuals who were diagnosed with acute lymphoblastic leukemia at ages 5 months to 2 years and, therefore, have arisen during fetal hematopoiesis in utero. This result provides unequivocal evidence for a prenatal initiation of acute leukemia in young patients. The method should be applicable to other fusion genes in children with common subtypes of leukemia and will be of value in attempts to unravel the natural history and etiology of this major subtype of pediatric cancer.


This item appears in the following Collection(s)

Show simple item record